#ExistInterpData>Refer to report.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration, however, FDA clearance or approval is not currently required for clinical use of this test. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
See Compliance Statement B: www.aruplab.com/CS
||Tyrosine Kinase Mutation (JAK2 Gene, V617F Mutation, Qualitative)